ArticleBlood2005

Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma.

Noopur Raje et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.